147 related articles for article (PubMed ID: 16602133)
1. C-type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration.
Pelisek J; Fuchs AT; Kuehnl A; Tian W; Kuhlmann MT; Rolland PH; Mekkaoui C; Gaedtke L; Nikol S
J Gene Med; 2006 Jul; 8(7):835-44. PubMed ID: 16602133
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of restenosis formation without compromising reendothelialization as a potential solution to thrombosis following angioplasty?
Fuchs AT; Kuehnl A; Pelisek J; Rolland PH; Mekkaoui C; Netz H; Nikol S
Endothelium; 2008; 15(1):85-92. PubMed ID: 18568948
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of genomic DNA, cDNA, and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells.
Pelisek J; Kuehnl A; Rolland PH; Mekkaoui C; Fuchs A; Walker GF; Ogris M; Wagner E; Nikol S
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1646-51. PubMed ID: 15231517
[TBL] [Abstract][Full Text] [Related]
4. C-type natriuretic peptide inhibits constrictive remodeling without compromising re-endothelialization in balloon-dilated renal arteries.
Kühnl A; Pelisek J; Tian W; Kuhlmann M; Rolland PH; Mekkaoui C; Fuchs A; Nikol S
J Endovasc Ther; 2005 Apr; 12(2):171-82. PubMed ID: 15823063
[TBL] [Abstract][Full Text] [Related]
5. [Effects of C-type natriuretic peptide gene transduction on neointimal hyperplasia and endothelial function after angioplasty].
Pei XY; Feng JZ; Qian WM; Yu XY; Wu SL; Yang PZ; Liu Y
Di Yi Jun Yi Da Xue Xue Bao; 2004 Apr; 24(4):400-3. PubMed ID: 15090308
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells.
Doi K; Itoh H; Ikeda T; Hosoda K; Ogawa Y; Igaki T; Yamashita J; Chun TH; Inoue M; Masatsugu K; Matsuda K; Ohmori K; Nakao K
Biochem Biophys Res Commun; 1997 Oct; 239(3):889-94. PubMed ID: 9367865
[TBL] [Abstract][Full Text] [Related]
7. Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells.
Kelsall CJ; Chester AH; Sarathchandra P; Singer DR
Vascul Pharmacol; 2006 Dec; 45(6):368-73. PubMed ID: 16914388
[TBL] [Abstract][Full Text] [Related]
8. [Gene transfer of interferon beta inhibits vascular smooth muscle cell proliferation in vitro and in animal model of arterial injury].
Stephan D; San H; Gordon D; Nabel GJ; Nabel EG
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1121-5. PubMed ID: 9404420
[TBL] [Abstract][Full Text] [Related]
9. Focal arterial transgene expression after local gene delivery.
Ma X; Glover C; Miller H; Goldstein J; O'Brien E
Can J Cardiol; 2001 Aug; 17(8):873-83. PubMed ID: 11521130
[TBL] [Abstract][Full Text] [Related]
10. Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model.
Pelisek J; Engelmann MG; Golda A; Fuchs A; Armeanu S; Shimizu M; Mekkaoui C; Rolland PH; Nikol S
J Mol Med (Berl); 2002 Nov; 80(11):724-36. PubMed ID: 12436349
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide preserves endothelial function during intimal hyperplasia.
Barber MN; Gaspari TA; Kairuz EM; Dusting GJ; Woods RL
J Vasc Res; 2005; 42(2):101-10. PubMed ID: 15665545
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
13. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo.
Armeanu S; Pelisek J; Krausz E; Fuchs A; Groth D; Curth R; Keil O; Quilici J; Rolland PH; Reszka R; Nikol S
Mol Ther; 2000 Apr; 1(4):366-75. PubMed ID: 10933955
[TBL] [Abstract][Full Text] [Related]
14. Tormentic acid reduces vascular smooth muscle cell proliferation and survival.
Fogo AS; Antonioli E; Calixto JB; Campos AH
Eur J Pharmacol; 2009 Aug; 615(1-3):50-4. PubMed ID: 19464287
[TBL] [Abstract][Full Text] [Related]
15. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin S expression is up-regulated following balloon angioplasty in the hypercholesterolemic rabbit.
Burns-Kurtis CL; Olzinski AR; Needle S; Fox JH; Capper EA; Kelly FM; McQueney MS; Romanic AM
Cardiovasc Res; 2004 Jun; 62(3):610-20. PubMed ID: 15158154
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidylcholine increases C-type natriuretic peptide expression in human vascular smooth muscle cells via membrane distortion.
Mendonça MC; Rezende A; Doi SQ; Sellitti DF
Vascul Pharmacol; 2009 Jul; 51(1):29-36. PubMed ID: 19275966
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel delivered to adventitia attenuates neointima formation without compromising re-endothelialization after angioplasty in a porcine restenosis model.
Tian W; Kuhlmann MT; Pelisek J; Scobioala S; Quang TH; Hasib L; Klocke R; Jahn UR; Nikol S
J Endovasc Ther; 2006 Oct; 13(5):616-29. PubMed ID: 17042659
[TBL] [Abstract][Full Text] [Related]
19. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
[TBL] [Abstract][Full Text] [Related]
20. [Liposome-mediated transfection of thrombomodulin in vascular smooth muscle cells--a gene therapy concept to inhibit recurrent stenosis].
Johst U; Khorchidi S; Bantleon R; Kehlbach R; Wiskirchen J; Rodegerdts E; Bierhaus A; Nawroth PP; Duda SH
Rofo; 2004 Mar; 176(3):398-403. PubMed ID: 15026954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
